BiotechTube
NEMA Research

NEMA Research

Naples, United States· Est.
nemaresearch.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

NEMA Research is a privately held, full-service Contract Research Organization (CRO) founded in 2012 and headquartered in Naples, Florida. It differentiates itself through a physician-founded, sponsor-driven model that leverages a proprietary network of key opinion leaders and research sites to accelerate clinical trial execution, with a special emphasis on the evolving regulatory landscape for nutraceuticals. The company is revenue-generating, offering end-to-end services from feasibility and protocol development to data management and regulatory submission, primarily serving pharmaceutical, medical device, and supplement companies.

OncologyInfectious DiseaseNeuroscience

Technology Platform

Proprietary network of physicians/hospitals, KOL Registry, dedicated IRB for nutraceuticals/supplements, and proprietary research methodologies/software (including 'HOPE Analysis').

Opportunities

The anticipated increase in FDA regulatory requirements for nutraceuticals and dietary supplements represents a major growth opportunity, leveraging their specialized IRB and expertise.
Additionally, the growing trend of outsourcing in biopharma R&D and the adoption of decentralized trial components provide a expanding total addressable market for their full-service CRO offerings.

Risk Factors

The company's niche strategy is heavily dependent on a potential FDA regulatory shift that may not materialize as expected.
It also faces intense competition from large, global CROs with greater resources, and its service-based model carries inherent reputation risk tied to the success of client trials.

Competitive Landscape

NEMA competes in the fragmented CRO market against global giants (e.g., IQVIA, ICON) and numerous small-to-mid-sized specialized CROs. Its primary differentiation is its physician-led, network-based model and its unique focus on the nutraceutical/supplement sector, including a dedicated IRB, which is a claimed first-in-class asset.

More companies in Digital Health & Biotech SaaS →More companies in United States →